Women's biological longevity

Preserve fertility. Postpone menopause.

Ovealth cryopreserves your ovarian tissue — the most powerful endocrine organ a woman has — to extend both your reproductive and hormonal future. Decades of your biology, kept available for when you need it.

200+
Live births reported worldwide from transplanted ovarian tissue
~85%
Of transplanted women recover natural ovarian hormone function
1st
US commercial program built for both fertility and longevity indications

Two futures, preserved in one procedure.

Your ovaries are not just reproductive organs — they are the body's most influential hormonal system. Ovealth preserves that system, giving you optionality on both your fertility timeline and your healthspan.

Pillar one

Fertility, on your timeline.

A single small piece of ovarian cortex contains thousands of follicles — far more than any egg freezing cycle can capture. Preserved today, it offers the possibility of biological children years after your natural fertility window would have closed.

  • Not a replacement for IVF — a deeper reserve behind it
  • Reactivates natural ovulation after transplantation
  • Pregnancies reported up to ~15 years post-preservation
Pillar two

Menopause, postponed.

Menopause is one of the most consequential hormonal transitions in a woman's life — accelerating bone loss, cardiovascular risk, cognitive decline, and metabolic shift. Your own tissue, grafted back, restores your own hormones in their natural rhythm — not a pill, not a patch.

  • Native estrogen, progesterone, and androgens in cyclical patterns
  • Alternative to synthetic HRT with different risk profile
  • Modeling suggests significant menopause delay — several years for a single transplant, potentially over a decade with fractionated transplants (Johnson & Oktay, AJOG 2024)

Four stages. One continuous arc.

A single outpatient procedure, ideally performed during peak ovarian reserve, sets up a preservation window that can span decades — from the moment tissue is retrieved to the moment, years later, when it's returned to your body.

01
Assess

Consultation & reserve assessment

Comprehensive baseline: AMH, AFC, full hormonal panel, family and reproductive history review, and consultation with a reproductive endocrinologist in our network.

02
Preserve

Minimally invasive procedure

A laparoscopic outpatient procedure removes a portion of one ovary. Same-day discharge. Most patients return to normal activity within three to five days.

03
Cryopreserve

Specialized tissue processing

Your tissue is processed at our cryobiology partner facility into thin cortical strips — the format with the strongest clinical evidence — and cryopreserved in liquid nitrogen.

04
Activate

Future transplantation

When you're ready — for pregnancy, or to delay menopause — your own tissue is thawed and transplanted in an outpatient procedure. Your hormones. Your timing. Your biology.

The storage window at the center of this cycle is where ovarian time is kept.

Relevant at different moments in a woman's life.

Ovarian tissue preservation has historically been offered to women facing cancer treatment. The clinical foundation now supports a broader set of situations — including women planning for ovarian health across decades.

α
Facing a medical treatment

Chemotherapy, radiation, stem cell transplant, or ovarian surgery for benign or malignant conditions — all can compromise ovarian function. OTC is one of the few options that preserves both fertility and hormone-producing tissue in a single procedure.

β
Elevated risk of early decline

Family history of early menopause, genetic predisposition (including BRCA or Turner-related conditions), or autoimmune factors that increase the likelihood of primary ovarian insufficiency.

γ
Long-term reproductive planning

Women who want to preserve ovarian tissue while their reserve is at its highest — to keep both fertility and long-term hormonal options open. Research in this area is active; we share what's established and what remains under investigation.

Final eligibility is confirmed through clinical consultation and assessment. Not a candidate today? Add yourself to the waitlist — we'll share updates as indications expand and as clinical access widens across the country.

Tell us what you're thinking.

Whether you're actively considering ovarian tissue preservation or just exploring, we'd like to hear from you. The information below helps us respond relevantly and match you to the right clinical partner when your region is live.

Why we ask for clinical details

The more we know about your ovarian reserve and family history, the more accurately we can assess fit and prepare relevant next steps. Everything is optional except name, email, age, and interest. Data is stored securely and used only to contact you about Ovealth.

About you
Your primary interest
Clinical context all optional
Anti-Müllerian hormone — primary ovarian reserve marker
Antral follicle count — from transvaginal ultrasound
One of the strongest predictors of your own ovarian timeline

Your information is kept strictly confidential. Ovealth does not sell or share patient data. You can request deletion at any time.

Questions, answered.

What is ovarian tissue cryopreservation, exactly?
A small piece of ovarian cortex — the outer layer of the ovary, which contains the follicle reserve — is removed in a laparoscopic outpatient procedure, processed into thin strips, and cryopreserved. The tissue can later be thawed and transplanted back into the body, where it reactivates and resumes its normal function: releasing eggs and producing hormones in their natural cyclical rhythm.
How is this different from egg freezing?
Egg freezing captures a single batch of mature eggs — usually 10 to 20 per cycle — and requires hormonal stimulation. Ovarian tissue preservation captures thousands of immature follicles in a single procedure, with no stimulation, and preserves your full hormonal system — not just gametes. The two approaches are complementary, not competitive.
What is the clinical evidence?
Ovarian tissue cryopreservation has been in clinical use for fertility preservation since the early 2000s. Over 200 live births have been reported worldwide from transplanted tissue, and ASRM removed the "experimental" label from the procedure in 2019 for medical fertility preservation. Using ovarian tissue preservation to delay menopause in healthy women is an active area of clinical research — it draws on the same biology and decades of transplantation data, but outcomes in healthy women specifically are still being characterized.
Is the procedure safe?
Laparoscopic ovarian biopsy is a well-established gynecological procedure. Complication rates are low and comparable to other outpatient laparoscopic procedures. All candidates are evaluated individually and eligibility is confirmed only after clinical consultation.
How much does it cost? Is it covered?
Specific pricing for the procedure, processing, and long-term storage will be shared during consultation. Oncology-indicated preservation is increasingly reimbursed by commercial insurance. For elective preservation, cash-pay is currently the most common pathway. We're tracking employer-benefit coverage and actively working toward broader insurance access as the commercial landscape evolves.
When will Ovealth be available in my city?
We are building clinical partnerships across the US on a hub-and-spoke model. Joining the waitlist helps us prioritize geographic rollout based on where candidates are concentrated. We will contact you when a partner site near you comes online.

The pause is optional.

You never know what the decade ahead holds. Preserve the biology that gives you options.

Join the waitlist →